You are here

Article info

Article menu
Download PDFPDF
Coronary artery disease
Original article
Prognostic impact of ß-blocker use in patients with stable coronary artery disease

Authors

  • Christophe Bauters Centre Hospitalier Régional et Universitaire de Lille, Lille, France Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France Faculté de Médecine de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Gilles Lemesle Centre Hospitalier Régional et Universitaire de Lille, Lille, France Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France Faculté de Médecine de Lille, Lille, France PubMed articlesGoogle scholar articles
  • Thibaud Meurice Polyclinique du Bois, Lille, France PubMed articlesGoogle scholar articles
  • Olivier Tricot Centre Hospitalier de Dunkerque, Dunkerque, France PubMed articlesGoogle scholar articles
  • Pascal de Groote Centre Hospitalier Régional et Universitaire de Lille, Lille, France Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France PubMed articlesGoogle scholar articles
  • Nicolas Lamblin Centre Hospitalier Régional et Universitaire de Lille, Lille, France Inserm U744, Institut Pasteur de Lille, Université Lille Nord de France, Lille, France Faculté de Médecine de Lille, Lille, France PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Christophe Bauters, Hôpital Cardiologique, CHRU de Lille, Boul. Prof. Leclercq, Lille Cedex 59037, France; christophe.bauters{at}chru-lille.fr
View Full Text

Citation

Bauters C, Lemesle G, Meurice T, et al
Prognostic impact of ß-blocker use in patients with stable coronary artery disease
Heart 2014;100:1757-1761.

Publication history

  • Received February 17, 2014
  • Revised May 10, 2014
  • Accepted May 25, 2014
  • First published June 19, 2014.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions